StockData

BioLargo, Inc. (BLGO) stock

BLGOOTCChemicals & Allied ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 0/30
$0.07+0.00 (+0.90%)

Close on Oct 19, 2026Market cap $23.27MP/E –Yield –

BioLargo cash

Cash and short-term investments held at the end of each period.

BioLargo's cash was $2.19M at Jun 30, 2026. For fiscal 2025 it was $3.88M, up 9.4% from the year before. Over ten years it grew 8.2% a year on average. The highest annual figure on record is $3.88M in fiscal 2025.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$3.88M+9.4%
FY2024Dec 31, 2024$3.55M+0.3%
FY2023Dec 31, 2023$3.54M+91.2%
FY2022Dec 31, 2022$1.85M+92.4%
FY2021Dec 31, 2021$962.00K+34.4%
FY2020Dec 31, 2020$716.00K+9.3%
FY2019Dec 31, 2019$655.00K0.0%
FY2018Dec 31, 2018$655.00K-33.8%
FY2017Dec 31, 2017$990.00K-48.2%
FY2016Dec 31, 2016$1.91M+8.3%
FY2015Dec 31, 2015$1.76M+1041.5%
FY2014Dec 31, 2014$154.46K+67.1%
FY2013Dec 31, 2013$92.44K-38.9%
FY2012Dec 31, 2012$151.19K+17.7%
FY2011Dec 31, 2011$128.50K-69.8%
FY2010Dec 31, 2010$425.07K+214.1%
FY2009Dec 31, 2009$135.35K–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$2.19M-37.0%
Q1 FY2026Mar 31, 2026$4.12M+60.8%
Q4 FY2025Dec 31, 2025$3.88M+9.4%
Q3 FY2025Sep 30, 2025$4.55M+17.1%
Q2 FY2025Jun 30, 2025$3.47M-27.2%
Q1 FY2025Mar 31, 2025$2.56M-40.9%
Q4 FY2024Dec 31, 2024$3.55M+0.3%
Q3 FY2024Sep 30, 2024$3.88M+27.6%
Q2 FY2024Jun 30, 2024$4.77M+33.3%
Q1 FY2024Mar 31, 2024$4.34M+32.8%
Q4 FY2023Dec 31, 2023$3.54M+91.2%
Q3 FY2023Sep 30, 2023$3.04M+139.9%
Q2 FY2023Jun 30, 2023$3.58M+191.6%
Q1 FY2023Mar 31, 2023$3.26M+235.1%
Q4 FY2022Dec 31, 2022$1.85M+92.4%
Q3 FY2022Sep 30, 2022$1.27M+15.5%
Q2 FY2022Jun 30, 2022$1.23M-9.7%
Q1 FY2022Mar 31, 2022$974.00K-27.4%
Q4 FY2021Dec 31, 2021$962.00K+34.4%
Q3 FY2021Sep 30, 2021$1.10M-1.7%
Q2 FY2021Jun 30, 2021$1.36M+12.4%
Q1 FY2021Mar 31, 2021$1.34M+80.2%
Q4 FY2020Dec 31, 2020$716.00K+9.3%
Q3 FY2020Sep 30, 2020$1.12M-47.7%
Q2 FY2020Jun 30, 2020$1.21M+71.0%
Q1 FY2020Mar 31, 2020$744.00K+45.3%
Q4 FY2019Dec 31, 2019$655.00K0.0%
Q3 FY2019Sep 30, 2019$2.14M+300.0%
Q2 FY2019Jun 30, 2019$706.00K+8.4%
Q1 FY2019Mar 31, 2019$512.00K-44.4%
Q4 FY2018Dec 31, 2018$655.00K-33.8%
Q3 FY2018Sep 30, 2018$534.00K-57.3%
Q2 FY2018Jun 30, 2018$651.00K+50.2%
Q1 FY2018Mar 31, 2018$921.00K-21.7%
Q4 FY2017Dec 31, 2017$990.00K-48.2%
Q3 FY2017Sep 30, 2017$1.25M-27.7%
Q2 FY2017Jun 30, 2017$433.54K–
Q1 FY2017Mar 31, 2017$1.18M–
Q4 FY2016Dec 31, 2016$1.91M–
Q3 FY2016Sep 30, 2016$1.73M–

More BioLargo figures

See a number that looks wrong?